Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Over the projected period, the global central venous catheter market is expected to be constrained by the COVID-19 pandemic. For example, a study published in Current Oncology, a Canadian Cancer Research Journal, in June 2020 evaluated the impact of the COVID-19 epidemic in China on Stage II and Stage III colon cancer patients receiving adjuvant chemotherapy treatment.

Furthermore, the worldwide central venous catheters market is likely to be hampered by a decline in the number of blood transfusions. For example, during the COVID-19 pandemic, extra problems occurred for blood transfusion as a result of lockdown, social isolation, and fear of blood virus transmission, according to an article published in the journal Transfusion Medicine and Hemotherapy in November 2021. Furthermore, the elderly, who gave the majority of blood donations, were among the most sensitive to the virus, resulting in reduced donations from them, according to the same source.

Read More:


Click here for Central Venous Catheter Market Report:


Click here for Central Venous Catheter Market Press Release:




Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe